Attached files

file filename
EX-23.1 - EXHIBIT 23.1 - ROCKET PHARMACEUTICALS, INC.brhc10020974_ex23-1.htm
EX-32.1 - EXHIBIT 32.1 - ROCKET PHARMACEUTICALS, INC.brhc10020974_ex32-1.htm
EX-31.2 - EXHIBIT 31.2 - ROCKET PHARMACEUTICALS, INC.brhc10020974_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - ROCKET PHARMACEUTICALS, INC.brhc10020974_ex31-1.htm
EX-10.23 - EXHIBIT 10.23 - ROCKET PHARMACEUTICALS, INC.brhc10020974_ex10-23.htm
EX-10.11 - EXHIBIT 10.11 - ROCKET PHARMACEUTICALS, INC.brhc10020974_ex10-11.htm
EX-4.8 - EXHIBIT 4.8 - ROCKET PHARMACEUTICALS, INC.brhc10020974_ex4-8.htm
10-K - 10-K - ROCKET PHARMACEUTICALS, INC.brhc10020974_10k.htm

Exhibit 21.1

Subsidiaries of Rocket Pharmaceuticals, Inc.

   
Subsidiary
 
Jurisdiction of Incorporation
 
Rocket Ownership
1.
 
Inotek Securities Corporation
 
Massachusetts
 
100%
2.
 
Rocket Pharmaceuticals, Ltd.
 
Cayman Islands
 
100%
3.
 
Rocket Foundation, Inc.
 
Delaware
 
100%
4.
 
Spacecraft Seven, LLC
 
Delaware
 
100%